Format
Sort by

Send to

Choose Destination

Search results

Items: 3

1.

Autoantibodies against the bactericidal/permeability-increasing protein from inflammatory bowel disease patients can impair the antibiotic activity of bactericidal/permeability-increasing protein.

Schinke S, Fellermann K, Herlyn K, Reichel PH, Fundke R, Stange EF, Gross WL, Schultz H.

Inflamm Bowel Dis. 2004 Nov;10(6):763-70.

PMID:
15626895
2.

ANCA against bactericidal/permeability-increasing protein, azurocidin, calprotectin and defensins in rheumatic and infectious diseases: prevalence and clinical associations.

Schultz H, Csernok E, Herlyn K, Reichel PH, Moosig F, Cornely OA, Fagerhol MK, Gross WL.

Clin Exp Rheumatol. 2003 Nov-Dec;21(6 Suppl 32):S117-20.

PMID:
14740437
3.

Bactericidal/permeability-increasing protein is expressed by human dermal fibroblasts and upregulated by interleukin 4.

Reichel PH, Seemann C, Csernok E, Schröder JM, Müller A, Gross WL, Schultz H.

Clin Diagn Lab Immunol. 2003 May;10(3):473-5.

Supplemental Content

Loading ...
Support Center